AGIM JUSUFI

DERBY, CT

This page merges CMS profile IDs: 11309418, 8807593 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$1,163.30

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $619.03 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $619.0320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2020 $29.961
2021 $122.881
2022 $267.164
2023 $124.271
2024 $619.0320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096589241 Novo Nordisk Inc $8.12 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096783085 Novo Nordisk Inc $87.46 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096808429 Novo Nordisk Inc $18.92 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096941335 Novo Nordisk Inc $17.09 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096941835 Novo Nordisk Inc $22.43 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097002836 Novo Nordisk Inc $18.48 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097125759 Novo Nordisk Inc $17.44 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097178264 Novo Nordisk Inc $12.76 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097194354 Novo Nordisk Inc $16.87 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097304458 Novo Nordisk Inc $8.48 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097321224 Novo Nordisk Inc $16.58 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097344190 Novo Nordisk Inc $14.95 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097510182 Novo Nordisk Inc $14.68 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097557204 Novo Nordisk Inc $15.02 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114724741 Exact Sciences Corporation $20.01 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116482889 GlaxoSmithKline, LLC. $84.96 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117979522 Boehringer Ingelheim Pharmaceuticals, Inc. $91.93 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136009337 Lilly USA, LLC $7.65 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136009585 Lilly USA, LLC $124.27 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136012049 Lilly USA, LLC $0.93 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 11309418, 8807593

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.